Results 1 to 10 of about 73,107 (244)
Some of the next articles are maybe not open access.

Sarcoidosis

Medical Clinics of North America, 1953
openaire   +2 more sources

Sarcoidosi

1998
GRASSI C   +4 more
openaire   +2 more sources

Environmental Risk Factors for Sarcoidosis

open access: yesFrontiers in Immunology, 2020
Sarcoidosis is a multisystem granulomatous disease that may affect any body organ. Sarcoidosis is associated with many environmental and occupational exposures. Because the exact immunopathogenesis of sarcoidosis is unknown, it is not known whether these
Marc Judson, Judson Marc A
exaly   +3 more sources

Sarcoidosis [PDF]

open access: yesOrphanet Journal of Rare Diseases, 2007
AbstractSarcoidosis is a multisystemic disorder of unknown cause characterized by the formation of immune granulomas in involved organs. It is an ubiquitous disease with incidence (varying according to age, sex, race and geographic origin) estimated at around 16.5/100,000 in men and 19/100,000 in women.
Valeyre Dominique   +3 more
  +13 more sources

Sarcoidosis [PDF]

open access: yesOphthalmology, 2015
Sarcoidosis is a disease characterized by noncaseating granulomatous infiltration of 1 or more organs. In North America, after the lungs and thoracic lymph nodes, the skin is the next most commonly involved organ. Data from multiple studies indicate a coaction between genetic and environmental factors in immunologically susceptible hosts. The disease's
Christopher K H, Burris   +2 more
  +10 more sources

SARCOIDOSIS [PDF]

open access: yesThe Lancet, 1960
The historical background to the disorder is unfolded. It was originally regarded as a dermatological curiosity, and later sarcoidosis was recognized as a disorder diffusely involving most tissues of the body. Clinical syndromes described include those presenting to the dermatologist, ophthalmologist, chest physician and radiologist, gastroenterologist
M M, CUMMINGS, M, MICHAEL
openaire   +10 more sources

Immune mechanisms in fibrotic pulmonary sarcoidosis

open access: yesEuropean Respiratory Review, 2022
Sarcoidosis is an immune-mediated disorder. Its immunopathology has been steadily mapped out over the past few decades. Despite this, the underpinning mechanisms for progressive fibrotic sarcoidosis is an almost uncharted area.
Praveen Weeratunga   +2 more
doaj   +1 more source

Gender differences in health-related quality of life measured by the Sarcoidosis Health Questionnaire

open access: yesScientific Reports, 2021
Sarcoidosis is granulomatous disease, which complex etiology is yet to be fully discovered. In the majority of cases its course is self-limiting. However it can have different clinical manifestations and can be debilitating condition with great impact on
Łukasz Gwadera   +6 more
doaj   +1 more source

Health-Related Quality of Life (HRQoL) in Sarcoidosis: Diagnosis, Management, and Health Outcomes

open access: yesDiagnostics, 2021
Health-related quality of life (HRQoL), though rarely considered as a primary endpoint in clinical trials, may be the single outcome reflective of patient priorities when living with a health condition.
Lesley Ann Saketkoo   +21 more
doaj   +1 more source

The Role of Echocardiography in the Contemporary Diagnosis and Prognosis of Cardiac Sarcoidosis: A Comprehensive Review

open access: yesLife, 2023
Cardiac sarcoidosis (CS) is a rare inflammatory disorder characterised by the presence of non-caseating granulomas within the myocardium. Contemporary studies have revealed that 25–30% of patients with systemic sarcoidosis have cardiac involvement, with ...
Joseph Okafor   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy